What sectors does Novartis Venture Fund invest in?

Novartis CVC investing $5-25M in innovative life science companies developing breakthrough biotech and biopharma therapeutics addressing unmet patient needs.

Typical check size

From €3M

Fund size: $750M (evergreen)

Browse similar check sizes →

Portfolio highlights

Forendo Pharma - women's health biotech, endometriosis (acquired by Organon, 2021)

Annexon Biosciences - complement biology therapeutics (Nasdaq-listed)

Contact

sosei.com

Switzerland

Research with AI

Learn more about Novartis Venture Fund using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what Novartis Venture Fund and similar investors look for:

Biotech pitch guide

More investors in Switzerland

4See Ventures ABB Ventures ACE & Company Affentranger Associates View all in Switzerland

Related resources

Pre-seed fundraising guide Pre-seed pitch deck guide Seed fundraising guide Seed pitch deck guide Series A fundraising guide Series A pitch deck guide

Fundraising in Switzerland

Tips, programs, and cultural notes

More Biotech investors

Abingworth ACF Investors Ahren Innovation Capital Almi Invest GreenTech View all Biotech investors

Corporate VC

Switzerland

Novartis Venture Fund

Investment focus

Sectors

Biotech

Investment stages

Geographic focus

Switzerland

United States

Europe

Asia

Investment thesis

Novartis CVC investing $5-25M in innovative life science companies developing breakthrough biotech and biopharma therapeutics addressing unmet patient needs.